Skip to content

Peter Provet

Breaking the stigma: The importance of listening to buprenorphine patients

Odyssey House President and CEO Dr. Peter Provet comments on how a recent article in the New York Times (“An Effective Treatment for Opioid Addiction Exists. Why Isn’t It Used More?”, February 16, 2025) on buprenorphine and stigma. The recent New York Times Magazine article on buprenorphine…

Read More

“Treatment is an investment at a bargain price that we cannot afford to pass up.”

Letter to the Editor Is Portland’s Decriminalization of Drug Use the Right Approach? In today’s New York Times, Dr. Peter Provet, Odyssey House President & CEO, responds to a recent article about Portland’s drug crisis. To the Editor: Re “A…

Read More

Pin It on Pinterest